Compare Johnson & Johnson (JNJ) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Occidental Petroleum Corporation — how do they compare? Johnson & Johnson trades at $249.77 (market cap $598.96B), while Occidental Petroleum Corporation trades at $56.06 (market cap $54.89B). The key difference: Johnson & Johnson is far larger — about 10.9× Occidental Petroleum Corporation's market cap, and Johnson & Johnson pays the higher dividend (2.15%). Which is the better fit depends on your goals.
| JNJ | OXY | |
|---|---|---|
Market Cap | $598.96B | $54.89B |
Volume | 6,156,228 | — |
Sector | Health | Energy |
52-Week High | $267.24 | $66.24 |
52-Week Low | $164.36 | $38.92 |
Enterprise Value | $631.90B | $75.98B |
Dividend Yield | 2.15% | 1.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $249.58, down 1.37% today, amid a generally bullish technical outlook with strong moving average signals. The company reported robust Q2 2026 earnings, beating EPS estimates and raising full-year guidance, with revenue growth to $94.19B in 2025 and a net income margin of 21.48%. Recent news highlights strong institutional interest and positive analyst sentiment, though the stock faces pressure from MedTech segment misses despite overall strength.
The outlook for JNJ remains positive, supported by solid fundamentals, a consistent dividend history, and upward revised earnings guidance. Key risks include competitive pressures in pharmaceuticals, regulatory hurdles, and execution challenges in the MedTech division. With a consensus price target of $279.33, representing ~12% upside, the stock offers a compelling opportunity for long-term investors, balanced by sector-specific volatility and macroeconomic factors.
Occidental Petroleum (OXY) trades at $55.36, up 0.91% with a bullish technical signal. The company shows strong profitability with 22.42% net income margin and has beaten earnings estimates for three consecutive quarters. Recent news highlights capital spending reductions and Permian Basin growth potential. Analyst consensus is positive with a $65.38 price target representing 18% upside potential from current levels.
OXY presents a compelling investment case with improving debt metrics and consistent earnings outperformance. However, declining revenue trends from $36.6B in 2022 to $21.6B in 2025 and oil price sensitivity remain key risks. The stock's premium valuation (P/E 74.14) requires sustained execution to justify current levels amid volatile energy markets.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
